Article Details
Retrieved on: 2021-02-08 07:07:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Monoclonal antibodies segment will also exhibit healthy growth at a CAGR of 7%, reaching revenues worth US$ 142.7 Mn by the end of 2024.
Article found on: soccernurds.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here